| 000 | 01271 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517100801.0 | ||
| 264 | 0 | _c20160906 | |
| 008 | 201609s 0 0 jpn d | ||
| 022 | _a0021-5384 | ||
| 024 | 7 |
_a10.2169/naika.105.25 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMisu, Hirofumi | |
| 245 | 0 | 0 |
_a[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines]. _h[electronic resource] |
| 260 |
_bNihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine _cJan 2016 |
||
| 300 |
_a25-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xcomplications |
| 650 | 0 | 4 |
_aSelenoprotein P _xmetabolism |
| 650 | 0 | 4 |
_aalpha-2-HS-Glycoprotein _xmetabolism |
| 773 | 0 |
_tNihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine _gvol. 105 _gno. 1 _gp. 25-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2169/naika.105.25 _zAvailable from publisher's website |
| 999 |
_c26094533 _d26094533 |
||